Podchaser Logo
Home
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

DrugPatentWatch

DrugPatentWatch – Pharmaceutical and Biotechnology Business…

A daily News and Politics podcast
Good podcast? Give it some love!
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

DrugPatentWatch

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

Episodes
DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

DrugPatentWatch

DrugPatentWatch – Pharmaceutical and Biotechnology Business…

A daily News and Politics podcast
Good podcast? Give it some love!
Rate Podcast

Episodes of DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

Mark All
Search Episodes...
The pharmaceutical industry is a high-stakes arena where innovation, investment, and intellectual property (IP) protection intersect. One of the most […]Source
Lipitor’s marketing strategy underwent a significant evolution as generic competition emerged, employing aggressive tactics to retain market share and brand […]Source
Patent Expirations and Generic Competition This week saw several major blockbuster drugs facing patent expirations, potentially opening the market for […]Source
Introduction Patent portfolios are critical assets for pharmaceutical companies, providing market exclusivity and protecting revenue streams for drug products. Effective […]Source
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]Source
Introduction In the rapidly evolving landscape of pharmaceutical patent disputes in China, injunctive relief has emerged as a critical tool […]Source
DrugChatter is an innovative AI-powered search and answer engine designed to revolutionize how we access and comprehend information. Harnessing the […]Source
Introduction: The United States Patent and Trademark Office (USPTO) has recently released a comprehensive study on drug patents and exclusivity […]Source
The 505(b)(2) regulatory pathway provides an attractive avenue for drug developers to bring new products to market by leveraging existing […]Source
In the high-stakes world of pharmaceuticals, patents play a pivotal role in safeguarding intellectual property and ensuring a return on […]Source
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area […]Source
Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same […]Source
A recent whitepaper by Hermann Mucke summarizes the steps to performing an FTO for drug repurposing: Overview An FtO analysis […]Source
The article “The devil is in the divisional: an analysis of divisional patents, deadlines, declarations and suggestions for future practice” […]Source
Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key […]Source
Sure, here’s a more detailed explanation with examples: Drug Patent Duration Drug patents are granted by the United States Patent […]Source
In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden. […]Source
In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions […]Source
Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate […]Source
The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent […]Source
A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to […]Source
A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP) […]Source
A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the […]Source
LACTOSE-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Lactose-Free Medicines from Amazon This […]Source
GELATIN-Free Medicines, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs. Buy Gelatin-Free Medicines on Amazon This […]Source
Rate

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features